Angioplasty Balloons Market Size, Share & Industry Analysis, By Product Type (Standard Balloons, Drug Coated Balloons, Cutting Balloons, and Others), By Application (Coronary Artery Disease, Peripheral Artery Disease, and Others), By Balloon Compliance (Compliant Balloons, Semi-compliant Balloons, and Non-compliant Balloons), By End User (Hospitals & ASCs, Specialty Clinics & Catheterization Labs, and Others), and Regional Forecast, 2026-2034

The global angioplasty balloons market size was valued at USD 2.97 billion in 2025 and is projected to grow from USD 3.13 billion in 2026 to USD 4.81 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period.

Angioplasty balloons are a tiny, medical-grade balloon attached to the tip of a catheter. The increasing prevalence of cardiovascular conditions, the growing preference for minimally invasive surgical procedures, and the expansion of healthcare infrastructure are driving the adoption rate of these devices in the market. The increasing aging population is further increasing the demand for vascular procedures, thereby boosting the adoption of the product.

For instance, according to the 2024 data published by the Centers for Disease Control & Prevention (CDC), approximately 1 in 20 adults aged 20 and older in the U.S. suffered from coronary artery disease.

The continuous technological advancements in angioplasty balloons among the major players, such as Medtronic and Boston Scientific Corporation, are further contributing to market growth.

Angioplasty Balloons Market Trends

Technological Advancements in Balloon Catheter Design to Drive Product Demand

Manufacturers are focusing on incorporating technological advancements in balloon catheter design, including the development of balloons that improve lesion crossing, controlled vessel dilation, procedural safety, and drug delivery. The conventional standard balloon angioplasty is evolving into a wider portfolio that includes non-compliant balloons, semi-compliant balloons, high-pressure balloons, lesion modification balloons, drug-coated balloons, perfusion balloons, and other balloon types designed for specific lesion types and procedural requirements.

Additionally, drug-coated balloons deliver antiproliferative drugs to the vessel wall without leaving a permanent implant. This “leave-nothing-behind” approach is gaining widespread clinical interest in both peripheral and coronary interventions. 

• For instance, in June 2023, Surmodics, Inc., a provider of medical device and in vitro diagnostic technologies to the healthcare industry, received FDA approval for the SurVeil drug-coated balloon (DCB).

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Preference for Minimally Invasive Procedures to Boost Market Growth

The increasing prevalence of chronic conditions, including coronary artery disease, and growing preference for minimally invasive procedures are resulting in the rising number of angioplasty procedures among the patient population, consequently driving the demand for the product in the market.

• For instance, according to 2021 data published by the Diagnostic and Interventional Cardiology, more than 965,000 angioplasties were performed each year in the U.S.

This, along with a shift toward procedures in outpatient settings and increasing healthcare expenditure, is further driving the adoption of these devices in the market. Therefore, the above factors, along with the growing emphasis by key companies on introducing R&D activities to launch novel devices, are anticipated to drive the adoption rate of these devices, thereby supporting the global angioplasty balloons market growth.

Market Restraints

High Cost Associated with Advanced Angioplasty Balloons to Limit Market Growth

The high cost associated with advanced angioplasty balloons is a major restraint on the market, especially in emerging healthcare systems and price-sensitive economies. Advanced devices, including cutting balloons, drug-coated balloons, ultra-high-pressure balloons, scoring balloons, and specialty non-compliant balloons, are associated with higher acquisition costs owing to precision catheter engineering, clinical validation requirements, complex coating technologies, and regulatory compliance costs.

Additionally, the higher costs and limited reimbursement policies make adoption challenging for hospitals and healthcare settings with limited procurement budgets, thereby hampering market growth.

• For instance, according to the 2025 statistics published by the Centers for Medicare and Medicaid Services (CMS), the retail price of the AGENT Paclitaxel-Coated Balloon Catheter is USD 5,500.

Market Opportunities

Expanding Cath Lab Capacity to Drive Market Growth

The rapid expansion of healthcare facilities in emerging economies, including Brazil and India, is resulting in increased cath lab capacity. The growing prevalence of chronic conditions and expansion of healthcare infrastructure are consequently increasing cath lab installations in healthcare settings. Additionally, public hospitals are adding cath labs to reduce procedure waiting times and dependence on tertiary referral centers, creating lucrative opportunities for manufacturers to strengthen their presence in the market.

• For instance, in February 2024, Koninklijke Philips N.V., a company in health technology, installed more than 1500 Cath Lab (interventional suite) in India.

Market Challenges

Limited Healthcare Access in Emerging Countries to Hamper Market Growth

There is a growing demand for minimally invasive surgical procedures among patients. However, the limited availability of technologically advanced devices, limited healthcare expenditure, along with inadequate reimbursement frameworks, especially in emerging countries, are resulting in limited access to healthcare facilities.

Furthermore, a limited number of clinical facilities and specialists are contributing to delays in angioplasty procedures, especially in developing countries, including Mexico and Brazil.

• For instance, according to 2023 data published by The World Bank Group (WBG), approximately 4.5 billion people lack full access to essential health services worldwide.

SEGMENTATION ANALYSIS

By Product Type

Increasing Prevalence of Chronic Conditions Boosted the Standard Balloons Segmental Growth

Based on product type, the market is classified into standard balloons, drug coated balloons, cutting balloons, and others.

The standard balloons segment held the largest market share in 2025. The growth is due to the increasing prevalence of chronic conditions among patients, resulting in a growing number of angioplasty procedures worldwide. This, along with the increasing emphasis of key companies on launching standard balloons, is further expected to contribute to the growth of the segment.

• For instance, according to 2026 statistics published by the National Center for Biotechnology Information, peripheral artery disease affects over 200 million adults globally.

To know how our report can help streamline your business, Speak to Analyst

The drug coated balloons segment is expected to grow at a CAGR of 6.5% over the forecast period.

By Application

Increasing Prevalence of Coronary Artery Disease Led to the Dominance of the Segment

Based on application, the market is segmented into coronary artery disease, peripheral artery disease, and others.

The coronary artery disease segment dominated the global market, registering a share of 67.1% in 2025. The segment’s growth is due to the increasing prevalence of coronary artery disease, resulting in a growing demand for angioplasty products, including angioplasty balloons.

• For instance, according to the 2023 data published by the Heart Foundation, approximately 590,000 people were affected by coronary heart disease in Australia.

The peripheral artery disease segment is set to grow at a CAGR of 6.0% during the forecast period.

By Balloon Compliance

Growing Number of Clinical Studies Supported the Semi-compliant Balloons Segment Growth

Based on balloon compliance, the market is segmented into compliant balloons, semi-compliant balloons, and non-compliant balloons.

The semi-compliant balloons segment dominated the global market, registering a share of 59.0% in 2025. The segment’s growth is due to the increasing prevalence of chronic cardiovascular conditions and the growing number of clinical studies, resulting in an increasing adoption of angioplasty balloon devices worldwide.

• For instance, according to a 2026 study published in the Journal of Clinical Cardiology, device and procedural success were achieved in 179 out of 183 patients (97.8%) when semi-compliant PTCA balloon pre-dilatation was used.

The compliant balloons segment is set to grow at a CAGR of 3.9% during the forecast period.

By End-user

Increasing Number of Angioplasty Procedures in Hospitals Encouraged the Hospitals & ASCs Segment Growth

Based on end user, the market is divided into hospitals & ASCs, specialty clinics & catheterization labs, and others.

The hospitals & ASCs segment dominated the market in 2025. The increasing prevalence of chronic disorders and the rising number of angioplasty procedures in hospitals are some of the major factors contributing to the growth of the segment in the market. Furthermore, the segment is set to hold an 88.2% share in 2026.

• For instance, according to 2025 statistics published by Definitive Healthcare, there were approximately 10,000 active ambulatory surgical centers in the U.S.

The specialty clinics & catheterization labs segment is projected to grow at a CAGR of 6.9% during the forecast period.

Angioplasty Balloons Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held the dominant share in 2024, valued at USD 1.06 billion, and also maintained its leading share in 2025, reaching USD 1.11 billion. The growing prevalence of chronic diseases, the rising number of hospitals, and growing technological advancements in these devices, including PTA balloon catheters, rising percutaneous coronary intervention (PCI) procedures, are some of the factors contributing to the growth of the segment in the market.

• For instance, according to 2026 statistics published by the American Hospital Association (AHA), there were about 6,100 hospitals in the U.S.

U.S. Angioplasty Balloons Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is expected to reach around USD 1.03 billion in 2026, accounting for roughly 32.8% of global sales.

Europe

Europe is projected to record a growth rate of 4.6% during the forecast period, which is the second-highest among all regions. The region is expected to reach USD 0.93 billion in 2026. The growing prevalence of chronic conditions and increasing adoption of agent drug coated balloon are likely to contribute to market growth.

U.K. Angioplasty Balloons Market

The U.K.’s market is estimated to reach around USD 0.15 billion in 2026, representing roughly 4.9% of global revenues.

Germany Angioplasty Balloons Market

Germany’s market is projected to reach approximately USD 0.22 billion in 2026, equivalent to around 7.0% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 0.75 billion in 2026, securing the position of the third-largest region in the market. The growing preference toward minimally invasive surgical procedures and rising adoption of drug-coated balloons (DCBs) are expected to contribute to the growth of the market.

Japan Angioplasty Balloons Market

The Japan market is estimated to reach around USD 0.18 billion in 2026, accounting for roughly 5.6% of global revenues. Japan has historically reported a relatively high prevalence of chronic disorders, along with growing adoption of advanced medical technologies.

China Angioplasty Balloons Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues standing at around USD 0.26 billion, representing roughly 8.4% of global sales.

India Angioplasty Balloons Market

The Indian market is estimated to reach around USD 0.11 billion in 2026, accounting for roughly 3.5% of global revenues.

Latin America and Middle East & Africa  

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market during the forecast period. The Latin America market is set to reach USD 0.17 billion in 2026.  The growth is due to increasing public healthcare investment and improved patient outcomes in the region. The Middle East & Africa market is also expected to grow due to the rising prevalence of cardiovascular diseases, including coronary artery diseases, and rising acquisitions and mergers among companies to strengthen their presence in the market. In the Middle East & Africa, the GCC is set to reach a value of USD 0.06 billion in 2026.

South Africa Angioplasty Balloons Market

The South Africa market is projected to reach around USD 0.02 billion in 2026, representing roughly 0.7% of global revenues.

Competitive Landscape

Key Industry Players

Key Players Focus on Receiving Approvals for Angioplasty Balloons to Boost Their Market Presence

Medtronic and Boston Scientific Corporation were the major companies in the market in 2025. A robust and diversified product portfolio, coupled with a significant focus on strategic initiatives globally, is one of the key factors contributing to the dominance of these companies in the market. Moreover, the growing focus of key companies on receiving approval for angioplasty balloons to strengthen their market presence is likely to contribute to the global angioplasty balloons market share.

• For instance, in March 2024, Boston Scientific Corporation received FDA approval for the AGENT Drug-Coated Balloon (DCB), which is indicated for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease.

Other key players, including Abbott, are also growing in the market, primarily due to their increasing focus on R&D activities to develop and introduce novel devices.

List of Key Angioplasty Balloons Companies Profiled

• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• Abbott (U.S.)
• BD (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Braun SE (Germany)
• Biosensors International Group (Singapore)                       
• Meril (India)
• Cordis (U.S.)
• Lepu Medical Technology (Beijing) Co., Ltd. (China)

KEY INDUSTRY DEVELOPMENTS

• April 2026: Cordis launched the SELUTION Sustained Limus Release (SLR) drug-eluting balloon (DEB) percutaneous transluminal angioplasty (PTA) in Japan.
• April 2026: Medtronic, a global company in healthcare technology, announced real-world data from the IN.PACT AV Access Post-Approval Study, demonstrating strong safety and effectiveness outcomes for the IN.PACT AV drug-coated balloon (DCB) in the treatment of arteriovenous fistula (AVF) stenoses in patients with end-stage kidney disease on dialysis.
• October 2025: Cagent Vascular launched 7- and 8-mm diameters of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter in the U.S.
• July 2024: Summa Therapeutics received FDA approval for Finesse Injectable angioplasty balloon catheters for percutaneous transluminal angioplasty treatment of peripheral artery disease, including infrapopliteal arteries.
• May 2023: Braun SE collaborated with Infraredx, a Nipro Company, to accelerate the FDA Investigational Device Exemption (IDE) clinical trial for the B. Braun SeQuent Please ReX Drug Coated PTCA Balloon Catheter.
• October 2022: Concept Medical received FDA Investigational Device Exemption (IDE) approval for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fistula in patients undergoing Haemodialysis for Chronic Renal Failure.

REPORT COVERAGE

The report provides a detailed global angioplasty balloons market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, application, balloon compliance, and end user. Besides this, the global report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation